Skip to content
Blerp – Lifestyle
Author:
Euroholdings Ltd.
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
August 12, 2026
EuroHoldings Ltd Reports Results for the Quarter and Six-Month Period, Ended June 30, 2026
August 12, 2026
EuroHoldings Ltd. Sets Date for the Release of Second Quarter 2026 Results, Conference Call and Webcast
August 10, 2026
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
August 5, 2026
Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System
August 4, 2026
Euroholdings Ltd Announces the Results of Its 2026 Annual Meeting of Shareholders
July 24, 2026
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
July 24, 2026
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
July 21, 2026
Euroholdings Ltd Announces 2026 Annual Meeting of Shareholders
June 23, 2026
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
June 16, 2026
1
2
Next Page
→